A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus—effects on slowphase eye velocity, postural stability, locomotion and symptoms | Journal of Neurology, Neurosurgery & Psychiatry
A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs - Journal of Biological Chemistry
Enrichment and characterization of a bacterial culture that can degrade 4- aminopyridine | BMC Microbiology | Full Text
Selective Effects of Subarachnoid Hemorrhage on Cerebral Vascular Responses to 4-Aminopyridine in Rats | Stroke
A PRESENTATION ON “In Ovo Mefloquine and 4-Aminopyridine administration inhibits chorioallantoic membrane (CAM) angiogenesis in chicken embryos through. - ppt video online download
Neuroprotective Properties of 4-Aminopyridine | Neurology Neuroimmunology & Neuroinflammation
Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers | Scientific Reports
Reactivity of 4-Aminopyridine with Halogens and Interhalogens: Weak Interactions Supported Networks of 4-Aminopyridine and 4-Aminopyridinium | Crystal Growth & Design
PDF] The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices. | Semantic Scholar
Structural, linear and nonlinear optical, electrical and NBO reports on 4- aminopyridine-1-ium 4-aminobenzoate single crystal for SHG, optoelectronics and violet laser emission applications | SpringerLink
Frontiers | The 4-Aminopyridine Model of Acute Seizures in vitro Elucidates Efficacy of New Antiepileptic Drugs | Neuroscience
Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine* - Journal of Biological Chemistry
Effect of 4‐Aminopyridine on Action Potential Parameters in Isolated Dog Purkinje Fibers - Thomas - 2010 - Archives of Drug Information - Wiley Online Library
Structure-activity relationship studies of four novel 4-aminopyridine K<sup>+</sup> channel blockers. - Abstract - Europe PMC
4-Aminopyridine (4-AP, BRL 34915, Dalfampridine, Fampridine, NSC 15041, CAS Number: 504-24-5) | Cayman Chemical
4-Aminopyridine Prevents the Conformational Changes Associated with P/C-Type Inactivation in Shaker Channels | Journal of Pharmacology and Experimental Therapeutics